Pamela Cyrus

Statistics

Publications

Citations

496

H-Index

Active since

1996

Affiliations

Bayer (United States)(Current)

Pamela Cyrus is an author at Bayer (United States) specializing in medicine, neurodegenerative disease pharmacotherapy, and pharmacological treatment of dementia.

Publications per year

1996–2005

Publications

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease

John C. Morris, Pamela Cyrus, John Orazem et al. · Neurology · 1998 · 289 citations

Medicine, Neurology, Pharmacotherapy +17

The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients

Murray A. Raskind, Pamela Cyrus, Bianca B. Ruzicka et al. · The Journal of Clinical Psychiatry · 1999 · 100 citations

Medicine, Neurology, Pharmacology +17

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Metrifonate in Patients with Probable Alzheimer Disease

John P. Blass, Pamela Cyrus, Florian Bieber et al. · Alzheimer Disease & Associated Disorders · 2000 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety and tolerability of metrifonate in patients with alzheimer's disease: Results of a maximum tolerated dose study

Neal R. Cutler, Stanford S. Jhee, Pamela Cyrus et al. · Life Sciences · 1998 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial

Michael W. Jann, Pamela Cyrus, Larry S. Eisner et al. · Clinical Therapeutics · 1999 · 20 citations

Medicine, Pharmacology, Pharmacotherapy +13

1–5 of 7